Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-17T13:19:17.014Z Has data issue: false hasContentIssue false

Use of intranasal corticosteroids in sinonasal infection and after surgery

Published online by Cambridge University Press:  26 February 2007

P J P Goonetilleke
Affiliation:
ENT Department, Leicester Royal Infirmary, Leicester, UK
D J Gatland
Affiliation:
ENT Department, Southend General Hospital, Southend, UK

Abstract

The use of intranasal steroids by otolaryngologists in the treatment of patients with infective rhinosinusitis and after endonasal surgery, particularly endoscopic sinus surgery, is unlicensed, as stated in the British National Formulary and in the manufacturers' leaflets supplied with nasal steroid medications. However, despite this, nasal steroids continue to be prescribed in these circumstances. Debate continues as to the exact role of intranasal steroids in sinonasal infection and after sinonasal surgery and whether their use in these circumstances should still be unlicensed.

This article reviews the current medical literature regarding this topic and aims to clarify whether intranasal steroid usage in these circumstances should be recommended.

Type
Review Articles
Copyright
2007 JLO (1984) Limited

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)